Among them, cellular tumor antigen p53 (TP53), myc proto-oncogene protein (MYC), transcription factor AP-1 (JUN), Src, Caspase-3 (CASP3), and EGFR play a key role in the anti-prostate cancer process of TsIIA, followed by CYT, which has more targets than the other two components. Here, EGFR is linked to prostate carcinoma.